Related Experiment Video

Updated: Sep 25, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.1K

Role of ANO1 in tumors and tumor immunity

Haini Li1, Zongxue Yu2, Haiyan Wang3

  • 1Department of Gastroenterology, Qingdao Sixth People's Hospital, Qingdao, 266001, China.

Journal of Cancer Research and Clinical Oncology
|April 26, 2022
PubMed

Insights

The calcium-activated chloride channel anoctamin 1 (ANO1) is implicated in cancer progression. This review explores ANO1

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Dysregulated cellular processes drive tumor growth and invasion.
  • Overexpression of anoctamin 1 (ANO1), a calcium-activated chloride channel, is linked to poor cancer prognosis.
  • The precise roles of ANO1 in malignant transformation and tumor immunity are not fully understood.

Purpose of the Study:

  • To review current research on ANO1's involvement in tumorigenesis.
  • To elucidate ANO1's function in tumor immunity and the tumor microenvironment.
  • To explore potential clinical applications of targeting ANO1.

Main Methods:

  • Literature review of recent studies on ANO1 in cancer.
  • Analysis of ANO1's roles across various cancer types.
  • Examination of ANO1's mechanisms in cancer progression and immunity.

Main Results:

  • ANO1 overexpression is observed in multiple cancer types, correlating with adverse outcomes.
  • ANO1 plays a significant role in tumor cell proliferation, invasion, and malignant transformation.
  • Emerging evidence suggests ANO1 influences tumor immunity and the tumor microenvironment.

Conclusions:

  • ANO1 is implicated in cancer development and progression.
  • ANO1's involvement in tumor immunity and the microenvironment presents it as a potential therapeutic target.
  • ANO1 may serve as a valuable biomarker for cancer prognosis and treatment.
Keywords:
ANO1DiagnosisDrug targetMarkerMechanismPrognosisTumor

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

733
Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

25.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
687
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K